Sugentech Inc.
Research Sugentech Inc. (253840.KQ) on Bullrun: market cap KRW 66.97B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker253840.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 66.97B
- Financial periodQ2 2026
- RevenueKRW 3.08B
- Net income-KRW 3.79B
- Free cash flow-KRW 4.55B
- Gross margin12.7%
Valuation Snapshot
latest market cap is KRW 66.97B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 66.97B | n/a | n/a | n/a |
About Sugentech Inc.
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sugentech Inc.'s market cap?
Sugentech Inc.'s market capitalization is KRW 66.97B.
What does Sugentech Inc. do?
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was formerly known as Accugen Healthcare, Inc.